Laboratory Assessment of Emicizumab Levels in Hemophilia A: Influence of Assay Selection on Reported Results

Background Emicizumab has emerged as a promising therapy for hemophilia A (HA), employing a bypassing mechanism to restore hemostasis. However, since the traditional factor assays cannot be used for measuring the effect of emicizumab, treatment monitoring is difficult. Objectives To assess the impac...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Charlotte Gran MD, PhD, Tony Frisk MD, PhD, Margareta Homström MD, PhD, Maria Magnusson MD, PhD, Susanna Ranta MD, PhD, Anna Sjöström MD, PhD, Marjan Shafaati Lambert, Nida Mahmoud Hourani Soutari BSc, Jovan P. Antovic MD, PhD, Roza Chaireti MD, PhD
Format:	Artigo
Sprog:	Inglês
Udgivet:	SAGE Publishing 2025-09-01
Serier:	Clinical and Applied Thrombosis/Hemostasis
Online adgang:	https://doi.org/10.1177/10760296251378458
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!